ledipasvir interMediate

ledipasvir interMediate Basic information
Product Name:ledipasvir interMediate
Synonyms:4)(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5- azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptanes-5-carboxylic acid 1,1-dimethylethyl ester;(6s)-TERT-BUTYL-6(5(7-BROMO-9,9-DIFLUORO-9h-FLUOREN-2-YI)-1h-IMIDAZOL-2YI)-5-AZASPIRO(2.4)HEPTANE-5-CARBOXYLATE;(6S)-6- [5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-IH-imidazol-2-yll-5-azaspiro;(S)-tert-butyl 6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;5-Azaspiro[2.4]heptane-5-carboxylic acid, 6-[5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl]-, 1,1-diMethylethyl ester, (6S)-;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester;tert-butyl (S)-6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate
CAS:1441670-89-8
MF:C27H26BrF2N3O2
MW:542.41
EINECS:939-899-8
Product Categories:
Mol File:1441670-89-8.mol
ledipasvir interMediate Structure
ledipasvir interMediate Chemical Properties
Boiling point 681.1±55.0 °C(Predicted)
density 1.53±0.1 g/cm3(Predicted)
storage temp. 2-8°C
pka11.13±0.10(Predicted)
Safety Information
MSDS Information
ledipasvir interMediate Usage And Synthesis
ledipasvir interMediate Preparation Products And Raw materials
(3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid ledipasvir interMediate 1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone (S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)- Ledipasvir (S)-2-((Methoxycarbonyl)aMino)-3-Methylbutanoic acid 2,7-DibroMo-9,9-difluoro-9H-fluorene ledipasvir interMediate ledipasvir interMediate

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.